SC
OKUR

Shay Capital’s OnKure Therapeutics OKUR Stock Holding History

Shay Capital’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Sell
50,000
-82,219
-62% -$353K 0.01% 390
2026
Q1 		$547K Sell
132,219
-648,642
-83% -$2M 0.05% 257
2025
Q4 		$2.26M Sell
780,861
-137,073
-15% -$410K 0.23% 105
2025
Q3 		$2.52M Buy
917,934
+135,888
+17% +$337K 0.22% 95
2025
Q2 		$1.87M Buy
782,046
+631,008
+418% +$1.65M 0.21% 76
2025
Q1 		$649K Buy
151,038
+136,022
+906% +$765K 0.09% 121
2024
Q4 		$129K Buy
15,016
+12,154
+425% +$184K 0.02% 268
2024
Q3 		$48.6K Buy
+2,862
New +$42.3K 0.01% 291

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Shay Capital's OKUR Position: Q2 2026 in Review

Shay Capital reduced its OnKure Therapeutics (OKUR) stake by 62% in Q2 2026, selling an estimated $353K and leaving 50,000 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #390.

Shay Capital first reported a position in OKUR in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.52M in Q3 2025. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Shay Capital held 50,000 shares of OnKure Therapeutics worth $228K as of Q2 2026.
  • Shay Capital sold 82,219 OnKure Therapeutics shares in Q2 2026, an estimated $353K.
  • OnKure Therapeutics made up 0.01% of Shay Capital's portfolio in Q2 2026, its #390 holding.
  • Shay Capital first reported a position in OnKure Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Shay Capital's OnKure Therapeutics position peaked at $2.52M in Q3 2025.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.